Reactivation of Chagas disease in a bone marrow transplant patient: Case report and review of screening and management

Transplant Infectious Disease

Volumn 15, Issue 6, 2013, Pages

  Guiang, K M U ^a   Cantey, P ^b   Montgomery, S P ^b   Ailawadhi, S ^c   Qvarnstrom, Y ^b   Price, T ^c   Blodget, E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Chagas disease; Parasites; Reactivation Chagas; Stem cell transplant; Transplant; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHAGAS DISEASE; COMPRESSION FRACTURE; DISEASE COURSE; DRUG MEGADOSE; EL SALVADOR; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; LUMBAR SPINE; MICROSCOPY; MULTIPLE MYELOMA; NEUTROPENIA; PARASITEMIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REMISSION; SALVAGE THERAPY; TISSUE INJURY;

CHAGAS DISEASE; PARASITES; REACTIVATION CHAGAS; STEM CELL TRANSPLANT; TRANSPLANT; TRYPANOSOMA CRUZI;

ANTIBODIES, PROTOZOAN; BONE MARROW TRANSPLANTATION; CHAGAS DISEASE; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; RECURRENCE; TRANSPLANTATION CONDITIONING; TRYPANOSOMA CRUZI;

EID: 84888872192     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12157     Document Type: Article

References (12)

1. The Foundation for the Accreditation of Cellular Therapy and the Joint Accreditation Committee - ISCT and EMBT. International Standards for Cellular Therapy Product Collection, Processing, and Administration. FACT-JACIE International Standards Accreditation Manual (4th edn.); 2008. Available at: http://www.cckl.nl/downloads/FACT-JACIE_4th_ed_Standards.pdf (accessed 2008).
2. Qvanstrom Y, Schijman AG, Veron V, Aznar C, Steurer F, da Silva AJ. Sensitive and specific detection of Trypanosoma cruzi DNA in clinical specimens using a multi-target real-time PCR approach. PLoS Negl Trop Dis 2012; 6 (7): e1689.
3. Diez M, Favaloro L, Bertolotti AM, et al. Usefulness of PCR strategies for early diagnoses of Chagas disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 2007; 7 (6): 1633-1640.
4. De Frietas VL, da Silva SC, Sartori AM, et al. Real-time PCR in HIV/Trypanasoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level. PLoS Negl Trop Dis 2011; 5 (8): e1277.
5. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009; 49 (5): e52-e54.
6. Riarte A, Luna C, Sabatiello R, et al. Chagas disease in patients kidney transplants. Clin Infect Dis 1999; 29 (3): 561-567.
7. Altclas J, Sinagra A, Dictar M, et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant 2005; 36: 123-129.
8. Bern C. Infections of the immunocompromised host. Curr Opin Infect Dis 2012; 25 (4): 450-457.
9. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 298 (18): 2171-2181.
10. Custer B, Agapova M, Bruhn R, et al. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion 2012; 52 (9): 1901-1911.
11. US Food and Drug Administration. Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); 2007. Available at: http://www.fda.gov/cber/tissue/docs.htm (accessed 2007).
12. Chin-Hong PV, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in Transplant Working Group. Am J Transplant 2011; 11: 672-680.